![Charmaine Gittleson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Charmaine Gittleson
Voorzitter bij
PERCHERON THERAPEUTICS LIMITED
Vermogen: 7 983 $ op 31-05-2026
Profiel
Charmaine Gittleson is currently Non-Executive Chairman at Percheron Therapeutics Ltd. since 2023, Independent Non-Executive Director at Polynovo Ltd. starting in 2026, and Non-Executive Director at George Medicines Pty Ltd. Former roles include Chairman at Patrys Ltd. from 2022 to 2025 and Chief Medical Officer at CSL Ltd. Education includes an undergraduate degree from the University of the Witwatersrand.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 31-12-2024 | 2.464.000 ( 0,16% ) | 7 983 $ | 31-05-2026 |
Actieve functies van Charmaine Gittleson
| Bedrijven | Functie | Begin |
|---|---|---|
| PERCHERON THERAPEUTICS LIMITED | Voorzitter | - |
| POLYNOVO LIMITED | Directeur/Bestuurslid | 01-04-2026 |
Eerdere bekende functies van Charmaine Gittleson
| Bedrijven | Functie | Einde |
|---|---|---|
| PATRYS LIMITED | Voorzitter | 17-06-2025 |
| CSL LIMITED | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Charmaine Gittleson
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
11
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
CSL Ltd.
 CSL Ltd. BiotechnologyHealth Technology Develops and manufactures medicines that treat people with rare and serious diseases | Health Technology |
Percheron Therapeutics Ltd.
 Percheron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes antisense pharmaceuticals | Health Technology |
Patrys Ltd.
 Patrys Ltd. Pharmaceuticals: MajorHealth Technology Develops novel antibody technologies for hard-to-treat cancers | Health Technology |
Polynovo Ltd.
 Polynovo Ltd. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
University of the Witwatersrand
 University of the Witwatersrand Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
